Call for an instant quote
0345 90 80 161
Open Mon to Fri 09:00 - 17:30 | Sat 09:00 - 16:00 (GMT)
30 November 2015 08:09
Breast cancer kills around 11,500 people in the UK each year
A combination of immunotherapy and chemotherapy could provide the key to treating breast cancer patients who have become resistant to existing drugs, new research suggests.
An international team of scientists tested the dual therapy on mice and say their results were "striking".
Experts at the Breast Cancer Care charity say they hope the study will be followed by further clinical trials and pave the way for the development of better treatments.
Researchers say the fact that the mice stayed free of cancer even after being given fresh tumours suggests the combined treatment provided them with ongoing immune protection.
Breast cancer has not previously been known to respond well to immunotherapy but pairing it with targeted chemotherapy produced some startling results, the research team says.
The therapy prevented tumours in the mice from being able to protect themselves from the immune system, enabling them to be attacked by cancer-fighting immune cells.
The type of cancer used by the team is one known as Her2 positive. It affects up to a fifth of all women with breast cancer and in the majority of cases results in patients becoming resistant to the drug Herceptin and other treatments.
But research leader Dr Philipp Muller, of Switzerland's University of Basel, says the technique made the tumours highly vulnerable to antibody-based immunotherapy.
It saw the mice given a chemotherapy drug and a variety of antibodies, including some which stopped the cancers shielding themselves from the animals' immune systems.
Breast cancer should not mean an end to life's luxuries, and holidaymakers can cover themselves with the help of cancer travel insurance policies.
Breast Cancer Care's Jackie Harris describes the research as interesting and a welcome forward step.
The clinical nurse specialist says the results of the early study open up the possibility of breast cancer patients who have become resistant to current drugs being treated in an alternative way in the future.
She adds that while Her2 positive breast cancer is hard to treat, research will provide the key to more effective treatments being developed.
The new study is published in the Science Translational Medicine journal.
24 February 2017
Heathrow airport has issued delay and cancellation warnings, after Storm Doris reached nearly 90mph on its way to batter Britain.
23 February 2017
Bowel cancer could be cut by more than a third amid the development of a one-off screening test, new research suggests.
22 February 2017
Hundreds of thousands of people with a potentially fatal genetic blood condition have yet to be diagnosed with the condition, a charity is warning.
21 February 2017
New technology to provide detailed scans of patients could improve the recovery of people suffering with liver cancer, scientists have said.
18 February 2017
At least 10 Britons have been injured in a speedboat accident off the icy coast of Norway.
17 February 2017
Comedian David Baddiel is trying to highlight the "epidemic" of dementia as a killer of older people in a new documentary.
16 February 2017
The public has spoken and the world's favourite cruises are being honoured by a top cruise review site.
15 February 2017
The collaborative #SkiSafe campaign has been relaunched in a bid to raise safety awareness among winter sports enthusiasts.
14 February 2017
A new "age defying" hormone could offer a breakthrough in preventing kidney and heart disease in people who suffer from diabetes.
11 February 2017
Patients needing new life-saving medication could have to wait two years after the UK leaves the EU, experts are warning.
10 February 2017
Families looking to take a cheap break in the upcoming half term are often sorely disappointed, however new research suggests Cyprus is the best destination for a well-priced trip.
09 February 2017
Europe remains the world's number one region as a travel destination - but tourism growth is slowing down, a travel industry report has said.